These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29308681)

  • 1. Therapeutic considerations of sarcopenia in heart failure patients.
    Saitoh M; Ebner N; von Haehling S; Anker SD; Springer J
    Expert Rev Cardiovasc Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29308681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms.
    Cho J; Choi Y; Sajgalik P; No MH; Lee SH; Kim S; Heo JW; Cho EJ; Chang E; Kang JH; Kwak HB; Park DH
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The wasting continuum in heart failure: from sarcopenia to cachexia.
    von Haehling S
    Proc Nutr Soc; 2015 Nov; 74(4):367-77. PubMed ID: 26264581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia and Heart Failure.
    Curcio F; Testa G; Liguori I; Papillo M; Flocco V; Panicara V; Galizia G; Della-Morte D; Gargiulo G; Cacciatore F; Bonaduce D; Landi F; Abete P
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31947528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
    Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
    Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle wasting and sarcopenia in heart failure and beyond: update 2017.
    Springer J; Springer JI; Anker SD
    ESC Heart Fail; 2017 Nov; 4(4):492-498. PubMed ID: 29154428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia.
    Tournadre A; Vial G; Capel F; Soubrier M; Boirie Y
    Joint Bone Spine; 2019 May; 86(3):309-314. PubMed ID: 30098424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction.
    Cho MR; Lee S; Song SK
    J Korean Med Sci; 2022 May; 37(18):e146. PubMed ID: 35535373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science.
    Lena A; Anker MS; Springer J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and investigational medications for the treatment of sarcopenia.
    Rolland Y; Dray C; Vellas B; Barreto PS
    Metabolism; 2023 Dec; 149():155597. PubMed ID: 37348598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle wasting and cachexia in heart failure: mechanisms and therapies.
    von Haehling S; Ebner N; Dos Santos MR; Springer J; Anker SD
    Nat Rev Cardiol; 2017 Jun; 14(6):323-341. PubMed ID: 28436486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise and Sarcopenia.
    Phu S; Boersma D; Duque G
    J Clin Densitom; 2015; 18(4):488-92. PubMed ID: 26071171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia in heart failure: mechanisms and therapeutic strategies.
    Collamati A; Marzetti E; Calvani R; Tosato M; D'Angelo E; Sisto AN; Landi F
    J Geriatr Cardiol; 2016 Jul; 13(7):615-24. PubMed ID: 27605943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease.
    Marty E; Liu Y; Samuel A; Or O; Lane J
    Bone; 2017 Dec; 105():276-286. PubMed ID: 28931495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia.
    Sakuma K; Yamaguchi A
    Pflugers Arch; 2018 Mar; 470(3):449-460. PubMed ID: 29043432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure.
    Gage JR; Fonarow G; Hamilton M; Widawski M; Martínez-Maza O; Vredevoe DL
    Neuroimmunomodulation; 2004; 11(3):173-80. PubMed ID: 15067208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient management of chronic heart failure.
    Kaldara E; Sanoudou D; Adamopoulos S; Nanas JN
    Expert Opin Pharmacother; 2015 Jan; 16(1):17-41. PubMed ID: 25480690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting Potential Pharmacological Interventions in Sarcopenia.
    Kilsby AJ; Sayer AA; Witham MD
    Drugs Aging; 2017 Apr; 34(4):233-240. PubMed ID: 28247316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new.
    Talameh JA; McLeod HL; Adams KF; Patterson JH
    J Card Fail; 2012 Apr; 18(4):338-49. PubMed ID: 22464776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.